Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Exactly Otto!...and I would love to see this as the next PR:
FDA advises PharmaCyte Biotech that it may begin clinical trials for its Clinical Trial in Pancreatic Cancer
:) :) :)
Go Team PharmaCyte!!!
:) :) :)
Agree :) :) :)
From Feb 26, 2018
PharmaCyte is working on an IND to submit to the FDA so that it can begin a clinical trial involving locally advanced, inoperable, non-metastatic pancreatic cancer and expects to submit its IND later this year .
“Later” is upon us. Hopefully, the development is finally coming to a positive end. With only less than 60 days left, that much anticipated major PR could soon be released. Announcing whether everything has been successfully completed and the IND has been submitted, or whether the IND was submitted and approved, it going to certainly be exciting either way.
Hopefully, we’re so very close. :) :) :)
Go Team PharmaCyte!!!
wth right? :) :) :)
Had to back the truck up for just a little bit more. Those buys are always interesting.
GO TEAM PHARMACYTE!!!!!
You missed the sarcasm.
And PharmaCyte’s progress is not measured by charts or by a clock of time, but rather their accomplishments and achievements toward completing their therapy development.
Patience.
Go Team PharmaCyte!!!
What is your chart predicting?
A secondary, yes, I totally agree as its IP alone would be the value driven means of income as licensing deals are struck with those companies in need of CiaB for their own drugs/therapies.
No partner needed. :)
Go Team PharmaCyte!!!
No, because there was no pump story in your post.
Perhaps you should study on the progress of science in general. More so, you should learn to be more patient with PharmaCyte’s therapy development.
I can guarantee you that the remedies you just mentioned took years to develop.
Being negative, or being a realist?
Also, don’t expect a pump pr (your carrot) from PharmaCyte.
Yes, KW may have made some premature assumptions along the way that proved to be incorrect, but for the most part PharmaCyte’s pr’s are always substantive news about progress.
No carrot here.
Go Team PharmaCyte!!!
lol You call that a carrot?
It’s merely a mentioning of the patent...a process that’s in order.
Go Team PharmaCyte!!!
Interesting....thanks Bio
Thanks efood!
Hey that’s a pretty and colorful chart Pete....what is it predicting?
I believe you guys could be right. Lots of potential either way. All its going to take is for the team to successfully complete the FDA/IND checklist.
CAN’T BE MUCH LEFT TO DO.
Get approval, and both funds and partner are sure to follow. :) :) :)
Go Team PharmaCyte!!!
They could possibly use it to learn the tolerance(s) of oxygen of an element within the chemical makeup of a therapy....having something to do with the tumors...just a guess.
The 855-Series (Anaaerobic Chamber) is designed for manually controlling your atmosphere when working with oxygen sensitive materials. It is perfect for working in situations requiring low levels of oxygen during critical isolation of the operator or your research materials. Any inert gas may be used.
It's main advantage is minimizing the risk of oxygen entry into the main working chamber. It trace amounts of O2 happen to enter the main chamber, the catalyst heater reduces it to water vapor. The installed drying train system can then be activated to remove any excess water vapor.
A bit about one use of an anaerobic chamber...
Live anaerobic bacteria can selectively grow in the hypoxic cores of tumors, but use of Clostridium perfringens (Cp) as a cancer therapy has been limited by toxic effects due to host inflammatory responses and to this bacterium ' s residual tolerance to oxygen.
Think of using our therapy instead.
Thanks Bio
Past and present charts NEVER have, nor NEVER will work for PharmaCyte while in its current standing.
Patience :) :) :)
Thanks RC
Go Team PharmaCyte!!!
By way of news or technicals?
lol NO!!! ...I refuse to take bad news
Hey Madd...I’m pretty sure he was at the farmers market at the time. :)
Certainly not from any kind of arbitrage event.
Seems as though they recorded and reported having one share of PharmaCyte....odd, but apparently not unusual as there are many other 1 share recordings as well.
At least it makes for another thrilling surmise. :) :) :)
Good morning my friend.
Go Team PharmaCyte!!!
Yes...or at least as close to that as we can.
Buy Buy Buy
Might wanna wait to buy until after the 100,000:1 reverse split on that one carrying 162BILLION outstanding shares. lol
Yes, but there was no specific day given.
I say EU
Not yet Madd...and besides, who knows, someone else can take interest and make MPX a better offer before January
lol Not really....4 to 5 months to start trials sounds about right.
After 20 years in making and 7 years in full development, when KW says “we are there” ...Tulla makes a reasonable measurement.
Go Team PharmaCyte!!!
I agree.
lol ok...if you say so. :)
Truthful or accurate?
Big difference my friend. :) :) :)
RC, my apologies. Honestly, I believe it’s fair to say “we all” have that same angst. :)
Yeah, but no matter how deep your angst is of his leadership, he certainly gets the credit for leading the team to critical achievements and progress. :) :) :)
...just saying
Go Team PharmaCyte!!!
Thank you!!! ....geeesh